China Pharma (NYSE:CPHI) & Acerus Pharmaceuticals (OTCMKTS:ASPCF) Financial Comparison

Volatility and Risk Acerus Pharmaceuticals has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, China Pharma has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Profitability This table compares Acerus Pharmaceuticals and China Pharma's net margins,